文献速递食管胃疾病与幽门螺杆菌消化道肿瘤与早癌消化内镜

巴雷特食管不足1 cm(不规则Z线)患者索引内镜检查后5年内高级别异型增生或食管腺癌风险低

Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy.
PubMed 文献 · Gastroenterology · 2016-12-15

前瞻性多中心队列研究纳入1791例索引内镜检查为非异型增生巴雷特食管患者,比较不规则Z线组(n=167)与巴雷特食管≥1 cm组(n=1624)进展为高级别异型增生或食管腺癌的发生率,中位随访5.9年。结果显示不规则Z线组无一例发生高级别异型增生或食管腺癌,全部71例事件均发生于巴雷特食管≥1 cm组。

要点

  • 不规则Z线组167例在中位随访4.8年内无高级别异型增生或食管腺癌发生。
  • 全部71例高级别异型增生或食管腺癌事件均发生于巴雷特食管≥1 cm组(n=1624)。
  • 不规则Z线组女性比例26.3%高于巴雷特食管组14.8%,吸烟者比例33.5%低于52.6%。

核心结论

  • 在索引内镜检查后5年内,不规则Z线患者未发生高级别异型增生或食管癌。

研究设计与样本

  • 前瞻性多中心队列研究,在美国和欧洲的三级转诊中心纳入1791例索引内镜检查为非异型增生巴雷特食管且随访1年以上的患者,平均年龄56±17岁。

主要发现

  • 不规则Z线组167例在中位随访4.8年(四分位距3.2-8.3年)内无一例发生高级别异型增生或食管腺癌。
  • 全部71例高级别异型增生或食管腺癌事件均发生于巴雷特食管≥1 cm组(n=1624)。
  • 不规则Z线组女性占26.3%,巴雷特食管组女性占14.8%(P<.001);不规则Z线组吸烟者占33.5%,巴雷特食管组吸烟者占52.6%。
  • 多因素分析中,不规则Z线与巴雷特食管≥1 cm两组在年龄、种族和随访时间上无显著差异。
  • 全体患者中位随访5.9年(四分位距3.1-8.3年)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Many patients with a < 1 cm segment of columnar metaplasia in the distal esophagus, also called an irregular Z line, are encountered. These patients, often referred to as patients with Barrett's esophagus (BE), are enrolled in surveillance programs. However, little is known about their risk of high-grade dysplasia (HGD) or esophageal adenocarcinoma (EAC). We aimed to determine the incidence of HGD and EAC in patients with irregular Z line with intestinal metaplasia. METHODS: We performed a prospective, multicenter cohort study of patients who underwent endoscopic examination for BE at tertiary care referral centers in the United States and Europe. We analyzed data from 1791 patients (mean age, 56 ± 17 years) found to have non-dysplastic BE at the index endoscopy and after 1 year or more of follow-up. Patients were followed for a median of 5.9 years (interquartile range, 3.1-8.3 years). We calculated rates of progression to HGD or EAC between groups of patients with irregular Z line (n = 167) and those with BE of ≥ 1 cm (n = 1624). RESULTS: A higher proportion of patients in the irregular Z-line group were female (26.3%) than in the BE group (14.8% female BE) (P <.001). A lower proportion of patients in the irregular Z-line group were smokers (33.5%) than in the BE group (52.6% smokers). None of the patients with irregular Z line developed HGD or EAC during a median follow-up period of 4.8 years (interquartile range, 3.2-8.3 years). All 71 incident cases of HGD or EAC developed in patients with BE of ≥1 cm in length. On multivariate analysis, patients with irregular Z line and patients with BE of ≥ 1 cm did not differ significantly in age, race, or duration of follow-up. CONCLUSIONS: In a prospective, multicenter cohort study, we found that patients with irregular Z line do not develop HGD or esophageal cancer within 5 years after index endoscopy.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Thota PN, Vennalaganti P, Vennelaganti S, et al. Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy. Gastroenterology. 2016. PMID: 27988383. doi:10.1053/j.gastro.2016.12.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。